EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RBM15 Mediated m6A Modification of SRSF1 Inhibits Cuproptosis in Non‐Small Cell Lung Cancer by Mediating ATP7B Alternative Splicing

Shan-Shan Mao, Dong-Yu Wu, Rong-Hua Cui, Xiao-Zhen Cheng iD

The Kaohsiung Journal of Medical Sciences · 2026

DOI: 10.1002/kjm2.70098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2026. Verfasst von Shan-Shan Mao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ward 1 of the Radiotherapy Department, The First Clinical College, The First Affiliated Hospital, Hainan Medical University, Haikou, Hainan, People's…. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Serine-Arginine Splicing Factors, Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Hainan Province Science and Technology Special Fund, Academic Enhancement Support Program of Hainan Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inhibition of cuproptosis contributes to the development of non‐small cell lung cancer (NSCLC). The expression of RNA‐binding motif protein 15 (RBM15) is upregulated in NSCLC. Nonetheless, its relationship with cuproptosis remains unclear. This study aimed to explore the role of RBM15 in regulating cuproptosis in NSCLC. A549 cells were treated with elesclomol (ES‐Cu) and tetrathiomolybdate (TTM) to induce or inhibit cellular cuproptosis. EdU, CCK‐8, Transwell assays, and flow cytometry were used to detect cellular phenotypes. The expression levels of relevant genes and proteins were analyzed using RT‐qPCR and western blotting. RIP and MeRIP were utilized to investigate the interaction of RBM15 and YT521‐B homology domain family‐3 (YTHDF3) with serine/arginine splicing factor 1 (SRSF1). The effect of the RBM15/m6A/SRSF1/ATP7B axis on tumor growth was evaluated using tumor xenografts in nude mice. Copper levels were assessed using commercially available kits. In NSCLC cells, RBM15 suppression inhibited proliferation and invasion while promoting cuproptosis; however, treatment with TTM (copper chelators) reversed the effect of sh‐RBM15. ES‐Cu treatment inhibited cell proliferation and invasion, and RBM15 knockdown further promoted the effect of ES‐Cu, but upregulated RBM15 reversed the regulatory effect of ES‐Cu. Mechanistically, RBM15 promoted the m6A modification of SRSF1 by recruiting YTHDF3. Increased SRSF1 enhanced ATPase copper‐transporting beta (ATP7B) exon 21 splicing. Furthermore, SRSF1 promoted cell proliferation and invasion and inhibited cuproptosis by regulating ATP7B alternative splicing. Finally, we verified that RBM15 promoted tumor growth by mediating SRSF1 in vivo. In short, RBM15‐mediated m6A modification enhanced SRSF1 stability, and SRSF1 promoted ATP7B alternative splicing to inhibit cuproptosis, thereby promoting NSCLC cell proliferation and tumor growth.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding ProteinsSerine-Arginine Splicing FactorsLung NeoplasmsCarcinoma, Non-Small-Cell LungAlternative SplicingCopper-Transporting ATPasesHumansAnimalsA549 CellsCell ProliferationMice, NudeMiceCopperGene Expression Regulation, NeoplasticMice, Inbred BALB C

Stichwörter der Autor:innen

NSCLCRBM15SRSF1alternative splicingcuproptosis

Substanzen

RNA-Binding ProteinsSerine-Arginine Splicing FactorsSRSF1 protein, humanCopper-Transporting ATPasesCopper

Autor:innen und Institutionen

  • Ward 1 of the Radiotherapy Department, The First Clinical College, The First Affiliated Hospital, Hainan Medical University, Haikou, Hainan, People's Republic of China.
  • Department of Medical Oncology, Haikou People's Hospital, Haikou, Hainan, People's Republic of China.

ORCID-Profile: Xiao-Zhen Cheng

Förderung

  • National Natural Science Foundation of China
  • Hainan Province Science and Technology Special Fund
  • Academic Enhancement Support Program of Hainan Medical University

Zitieren

APA

Mao, S. S., Wu, D. Y., Cui, R. H., & Cheng, X. Z. (2026). RBM15 Mediated m6A Modification of SRSF1 Inhibits Cuproptosis in Non‐Small Cell Lung Cancer by Mediating ATP7B Alternative Splicing. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.70098

Vancouver

Mao SS, Wu DY, Cui RH, Cheng XZ. RBM15 Mediated m6A Modification of SRSF1 Inhibits Cuproptosis in Non‐Small Cell Lung Cancer by Mediating ATP7B Alternative Splicing. The Kaohsiung Journal of Medical Sciences. 2026. doi:10.1002/kjm2.70098

BibTeX
@article{Mao2026,
  author = {Mao, Shan-Shan and Wu, Dong-Yu and Cui, Rong-Hua and Cheng, Xiao-Zhen},
  title = {RBM15 Mediated m6A Modification of SRSF1 Inhibits Cuproptosis in Non‐Small Cell Lung Cancer by Mediating ATP7B Alternative Splicing},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2026},
  doi = {10.1002/kjm2.70098}
}
Kostenlos starten →